Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6

Cancer Science

Volumn 99, Issue 1, 2008, Pages 166-172

  Yumita, Nagahiko ^a   Han, Qing Song ^a   Kitazumi, Ikuko ^a   Umemura, Shin Ichiro ^b  

^a TOHO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHLORINE DERIVATIVE; DNA FRAGMENT; HISTIDINE; MONO ASPARTYL CHLORIN E6; NITROXIDE; OXYGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL STRUCTURE; CONTROLLED STUDY; ECHOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPOSURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; HL-60 CELLS; HUMANS; NECROSIS; NITROGEN OXIDES; PHOTOSENSITIZING AGENTS; PORPHYRINS; REACTIVE OXYGEN SPECIES; ULTRASONIC THERAPY;

EID: 36949039664     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00653.x     Document Type: Article

References (35)

1. Kremkau FW. Cancer therapy with ultrasound. J Clin Ultrasound 1979; 7: 287.
2. Lele PP. Local hyperthermia by ultrasound. In: Nussbaum GH, ed. Physical Aspects of Hyperthermia. New York: American Institute of Physics, 1982; 393-440.
3. Rosenthal I, Sostaric ZJ, Riesz P. Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004; 11: 349-63.
4. Yu T, Wang Z, Mason TJ. A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 2004; 11: 95-103.
5. Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R. Recent advances in sonodynamic approach to cancer therapy. Ultrason Sonochem 1996; 3: S187-91.
6. Tachibana K, Uchida T, Hisano S, Morioka E. Eliminating adult T-cell leukaemia cells with ultrasound. Lancet 1997; 349: 9048.
7. Abe H, Kuroki M, Tachibana K et al. Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res 2002; 22: 1575-80.
8. Bellnier DA, Ho YK, Panday RK, Missert JR, Dougherty TJ. Distribution and elimination of Photofrin II in mice. Photochem Photobiol 1989; 50: 221-8.
9. Dougherty TJ. Photodynamic therapy. Photochem Photobiol 1993; 58: 895-905.
10. Umemura S, Yumita N, Nishigaki R. Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX70. Jpn J Cancer Res 1993; 84: 582-8.
11. Umemura S, Yumita N, Nishigaki R, Umemura S. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 1990; 81: 962-6.
12. Umemura K, Yumita N, Nishigaki R, Umemura S. Sonodynamically induced antitumor effect of pheophorbide a. Cancer Lett 1996; 102: 151-7.
13. Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S. Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2-vinyl-deuterio-porphynyl (IX)-6,7 diaspartic acid (ATX-S10). Jpn J Cancer Res 2000; 91: 255-60.
14. Yumita N, Umemura S, Nishigaki R. Ultrasonically induced cell damage enhanced by photofrin II: Mechanism of sonodynamic activation. In Vivo 2000; 14: 425-9.
15. Yumita N, Nishigaki R, Umemura S. Sonodynamically induced antitumor effect of photofrin II on colon 26 carcinoma. Cancer Res Clin Oncol 2000; 126: 601-06.
16. Yumita N, Sasaki K, Umemura S, Nishigaki R. Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 1996; 87: 310-16.
17. Yumita N, Umemura S. Sonodynamic therapy with photofrin II on AH130 solid tumor. Pharmacokinetics, tissue distribution and sonodynamic antitumoral efficacy of photofrin II. Cancer Chemother Pharmacol 2003; 51: 174-8.
18. Spikes JD, Bommer JC. Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): A candidate sensitizer for the photodynamic therapy of tumors. Photochem Photobiol 1993; 58: 346-50.
19. Gomer CJ, Ferrario A. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res 1990; 50: 3985-90.
20. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
21. Schemp CM, Simon-Haarhaus B, Termeer CC et al. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett 2001; 493: 26-30.
22. Vantieghem A, Assefa Z, Vandenabeele P et al. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett 1998; 440: 19-24.
23. Feril LB Jr, Kondo T, Takaya K, Riesz P. Enhanced ultrasound-induced apoptosis and cell lysis by a hypotonic medium. Int J Radiat Biol 2004; 80: 165-75.
24. Feril LB Jr, Tsuda Y, Kondo T et al. Ultrasound-induced killing of monocytic U937 cells enhanced by 2,2′-azobis (2-amidinopropane) dihydrochloride. Cancer Sci 2004; 95: 181-5.
25. Feril LB Jr, Kondo T, Ogawa R, Zhao QL. Dose-dependent inhibition of ultrasound-induced cell killing and free radical production by carbon dioxide. Ultrason Sonochem 2003; 10: 81-4.
26. Ashush H, Rozenszajn LA, Blass M et al. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure. Cancer Res 2000; 60: 1014-20.
27. Lagneaux L, de Meulenaer EC, Delforge A et al. Ultrasonic low-energy treatment: A novel approach to induce apoptosis in human leukemic cells. Exp Hematol 2002; 30: 1293-301.
28. Feril LB Jr, Kondo T, Zhao QL et al. Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol 2003; 29: 331-7.
29. Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol 1991; 54: 659.
30. Hiraoka H, Honda H, Feril LB Jr, Kudo N, Kondo T. Comparison between sonodynamic effect and photodynamic effect with photosensitizers on free radical formation and cell killing. Ultrason Sonochem 2006; 13: 535-42.
31. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd edn. New York: Oxford University Press, 1985.
32. Goldstein S, Czapski G. Mannitol as OH scavenger in aqueous solutions and biological systems. Int J Radiat Biol 1984; 46: 725-9.
33. Misik V, Riesz P. Free radical intermediates in sonodynamic therapy. Ann NY Acad Sci 2000; 899: 335-48.
34. Yeh SL, Yang TH, Huang CH et al. Exposure of calf thymus DNA to autoxidized β-carotene results in the formation of 8-oxo-deoxyguanosine. Food Chem 2003; 81: 439-45.
35. Van der Zee J, Van Steveninck J, Koster JF et al. Inhibition of enzymes and oxidative damage of red blood cells induced by t-butylhydroperoxide-derived radicals. Biochim Biophys Acta 1989; 980: 175-80.